Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This board is still up!
Actually they listened to me... this volume isn’t real. This is call rooms and promo. The volume says everything. The bonus changes would not be a driver like this.
Hey cats. I am going to close down this board. It is a duplicate to the MMEN board.
Home > Boards > Canadian > Cannabis > MEDMEN (MMEN)
Hey cats. I am going to close down this board. It is a duplicate to the MMEN board.
Home > Boards > Canadian > Cannabis > MEDMEN (MMEN)
Hey cats. I am going to close down this board. It is a duplicate to the MMEN board.
Home > Boards > Canadian > Cannabis > MEDMEN (MMEN)
that's no longer valid. Management listened to investors and created a more level playing field.
Old news. They backtracked a bit.
That sounds pretty damn bad. Greed is going to hurt a lot of these companies and def this one. Could be a good short soon when it's realized that the only ones getting mega rich are the insiders. Up nicely today but can see it taking a huge hit like most weed plays. GL
MedMen Revises Executive Compensation Plans
June 08, 2018 05:02 PM Eastern Daylight Time
LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (CSE: MMEN) (“MedMen”), the country’s leading cultivator, producer and retailer of state-sanctioned cannabis, announced today that the grant units for its co-founders under its long-term incentive plan (the “LTIP”) will now vest upon achievement of certain share price goals.
Co-founder and CEO Adam Bierman and Co-founder and President Andrew Modlin will receive their LTIP units of MM Enterprises USA LLC according to the following schedule. One third of the total units will vest when the price of MedMen’s Subordinated Voting Shares reaches CA$ 10 in the open market, another third will vest when the share price reaches CA$ 15 and the final third when the share price reaches CA$ 20. The price will be determined as a 5-day VWAP in any exchange where MedMen shares are traded.
This modification to the grants under the LTIP was made to provide greater economic alignment with MedMen’s shareholders.
About MedMen
MedMen Enterprises is the preeminent cannabis company in the United States with multiple assets and operations in California, Nevada and New York, which combined account for nearly half of North America’s addressable legal market. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is one of the most well recognized cannabis brands in the world today. Headquartered in Los Angeles, MedMen employs 800 workers across the United States. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to re-define our society’s relationship with cannabis. MedMen supports sensible, clear and just drug laws. The Company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates. For more information, visit http://www.medmen.com or follow us on Facebook, Twitter or Instagram.
Source: MedMen Enterprises
Contacts
Media Contact:
Daniel Yi
Senior Vice President of Corporate Communications, MedMen Enterprises
daniel@medmen.com
or
Investor Relations Contact:
Quote:
"Hello MEDMEN,
I was super excited about Medmen trading publicly in CA and eventually with a U.S. foreign issue OTC ticker. I opened a couple discussion boards on Investors HUB and was truly excited about investing in stock in this company.
I live in the U.S.
And then came the press about the use of the public company initial proceeds and the percentage of the company that individual investors would hold when investing in company shares.
The numbers here are rough and approximate.
Of the $100,000,000 in proceeds, approx half of that went directly into the pockets of the principals.
Roughly 7 percent of the company is owned by investors of company stock.
These numbers are ghastly and I declined to invest in Medmen.
How is the company going to repair its tarnished image with the investment community?"
JohnCM
MedMen Opens Marijuana Store on 'The Coolest Block in America'
Los Angeles - June 9, 2018 - GQ Magazine called Abbot Kinney "the coolest block in America." It just got cooler.
MedMen Enterprises Inc. (CSE: MMEN) ("MedMen"), the most recognized cannabis brand in the world with stores in Beverly Hills and New York's Fifth Avenue, opened its newest store on Venice's Abbot Kinney Boulevard on Saturday.
With banks of news media cameras surrounding the storefront, MedMen co-founders, Adam Bierman and Andrew Modlin, cut the ribbon. They were flanked by U.S. Congressman Ted Lieu, California State Senator Ben Allen, Assemblymember Reggie Jones-Sawyer and celebrity Rosario Dawson. Lines of customers waited to enter the store.
Lieu, whose district includes Abbot Kinney, welcomed customers and greeted the press. It marked the first known time an active U.S. congressman was featured in the grand opening of a marijuana dispensary. It underscored how mainstream marijuana has become, and how California is leading the way.
"I'm a big supporter of MedMen. It's the second store in my district and I've always been a big supporter of cannabis legalization," said Lieu. "In Washington D.C., I have been a co-author of numerous bills to legalize marijuana, to decriminalize it and to make sure that we can have federal banking for cannabis related transactions."
California is the largest legal cannabis market in the world, with total state-sanctioned annual sales projected to reach $7.7 billion by 2021. Nationally, state-sanctioned marijuana sales are projected to reach $75 billion by 2030.
MedMen is the largest U.S.-based company in the emerging cannabis industry with cultivation, manufacturing and retail facilities in California, Nevada and New York. The company recently announced it has acquired a medical marijuana license in Florida with right to open 25 dispensaries.
MedMen Abbot Kinney showcases the brand's signature iPad menus, bud cases and stylish décor. It is the company's thirteenth store nationwide. Abbot Kinney Boulevard, in the heart of beachfront town Venice, is one of the trendiest shopping districts in Los Angeles. Forbes calls Abbot Kinney "quintessential LA."
"Abbot Kinney combines the comfortable, laid back feel of Venice with some of the best retail, food and drink the West Coast has to offer," Bierman said. "Today is a truly historic moment. We are standing in front of a marijuana store among some of the most popular restaurants and shops in a major American city, in one of the most popular shopping destinations in the world. This is what mainstreaming marijuana looks like."
ABOUT MEDMEN:
MedMenEnterprises is the preeminent cannabis company in the U.S. and the emerging industry's most recognized brand, with assets and operations nationwide. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation's largest financial supporters of progressive marijuana laws. Visit http://www.medmen.com.
MEDIA CONTACT:
Briana Chester
Briana.Chester@medmen.com
1-424-465-4419
Thanks all! Let me know how it goes with TD; I haven't been able to get anywhere with them, as they can't find the symbol.
Thanks John! I have a Fidelity and had a Scottrade that changed to a TDAmertrade account. I am going to speak to them on Monday. Cheers!
"I understand. I read somewhere it takes a month or two.
Thanks again!"
JohnCM
From: Stephanie Van Hassel [mailto:stephanie@medmen.com]
Sent: Friday, June 8, 2018 11:07 PM
To: JohnCM
Subject: Re: MedMen Will Commence Trading May 29th Under Ticker Symbol "MMEN"
Hi John,
The new ticker is not DTC eligible at this moment in time.
Kind regards,
Stéphanie
Sent from my iPhone
On Jun 8, 2018, at 20:52, John wrote:
I have your new sponsored OTC ticker. Do you happen to know if it is DTC eligible yet?
Thank you ... Good move! Reacting and staying flexible. Good sign.
MedMen Revises Executive Compensation Plans
June 08, 2018 05:02 PM Eastern Daylight Time
LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (CSE: MMEN) (“MedMen”), the country’s leading cultivator, producer and retailer of state-sanctioned cannabis, announced today that the grant units for its co-founders under its long-term incentive plan (the “LTIP”) will now vest upon achievement of certain share price goals.
Co-founder and CEO Adam Bierman and Co-founder and President Andrew Modlin will receive their LTIP units of MM Enterprises USA LLC according to the following schedule. One third of the total units will vest when the price of MedMen’s Subordinated Voting Shares reaches CA$ 10 in the open market, another third will vest when the share price reaches CA$ 15 and the final third when the share price reaches CA$ 20. The price will be determined as a 5-day VWAP in any exchange where MedMen shares are traded.
This modification to the grants under the LTIP was made to provide greater economic alignment with MedMen’s shareholders.
About MedMen
MedMen Enterprises is the preeminent cannabis company in the United States with multiple assets and operations in California, Nevada and New York, which combined account for nearly half of North America’s addressable legal market. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is one of the most well recognized cannabis brands in the world today. Headquartered in Los Angeles, MedMen employs 800 workers across the United States. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to re-define our society’s relationship with cannabis. MedMen supports sensible, clear and just drug laws. The Company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates. For more information, visit http://www.medmen.com or follow us on Facebook, Twitter or Instagram.
Source: MedMen Enterprises
Contacts
Media Contact:
Daniel Yi
Senior Vice President of Corporate Communications, MedMen Enterprises
daniel@medmen.com
or
Investor Relations Contact:
If you trade on Fidelity, start a trade and it should tell you if the $50 charge applies. I do not know if the new company sponsored ticker is DTC eligible.
If you trade TDAmeritrade, fee is waived.
Average in ...
Why is that? I am considering buying some.
I am small time so I am not a fan of paying $50 usd per transaction. From what I read I think this company will do very well and will be a leader in the industry and maybe get bought out. Do you have thoughts or information to the contrary?
Any knowledge you have to share would be much appreciated!
I'd suggest shorting this fraud.
I can't believe this board is still alive!!
IHUB “Cannabis” discussion boards
Please participate!
Canadian Weed!
California Gold Rush Hot Marijuana Stocks
Cannabis Canadian and U. S. Priced At $0.75 to $10.00
Cannabis Best Opportunity Stocks $0.10 to $0.75
Cannabis Investment Club
Cannabis IPO Watch CA and US
If this is true... this is going to be crazy
With Canadian stocks (not on US exchanges). It costs $50 per transaction. You may have to call in your orders.
How can I buy this stock from the US? Symbol not listed on TD Ameritrade.
Yes!!! We have the other CA board MMEN
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
29
|
Created
|
06/05/18
|
Type
|
Free
|
Moderators |
MedMen’s headquarters is located at:
10115 Jefferson Boulevard
Culver City, CA 90232
1-855-292-8399
MedMen became a publicly traded company through a reverse takeover, or RTO, on May 29th, 2018.
Our stock trades on the Canadian Securities Exchange or CSE and the stock symbol is MMEN.
Our stock can be purchased by contacting a registered stock broker or through an online stock brokerage service for self-directed investors.
No. We do not expect to pay any dividends on our common stock in the foreseeable future.
The cusip for MMEN is 58507M107.
Odyssey Trust Company
United Kingdom Building
835 – 409 Granville Street
Vancouver, BC V6C 1T2
Phone: 1 (778) 819-1184
Email: info@odysseytrust.com
Website: www.odysseytrust.com
Shareholders with inquiries about their holdings, such as share count, address corrections or changes in registered share ownership, should contact our stock transfer agent.
Odyssey Trust Company
United Kingdom Building
835 – 409 Granville Street
Vancouver, BC V6C 1T2
Phone: 1 (778) 819-1184
Email: info@odysseytrust.com
Website: www.odysseytrust.com
Our fiscal year ends June 30th.
MedMen's independent registered public accounting firm is MNP LLC.
You can contact MedMen Investor Relations with questions related to our stock:
Investors@medmen.com
(855) 292-8399
Our public securities filings are available on www.sedar.com.
Please submit your e-mail address on the “Email Alerts” page of this website.
No, MedMen is not accepting applications for franchisees at this time.
MMNFF OTC
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |